News

In a small trial across ten U.S. research sites, a novel HIV vaccine candidate has shown a result that has eluded scientists ...
We may be a step closer to a highly effective mRNA vaccine against HIV, but tests so far reveal that the approach can cause ...
Scientists used a mRNA-based vaccine to reliably trigger antibodies that block HIV infection in people and monkeys ...
Results from early-stage trial show that 80% of participants who received one of two HIV vaccine candidates produced antibodies against viral proteins.
The results suggest the possibility of a vaccine for HIV/AIDS, which killed more than half a million people last year.
A Johns Hopkins vaccine expert discusses what a lack of funding could mean for future health after Robert F. Kennedy cut $500 million in vaccine contracts.
Former Surgeon General Jerome Adams, who served under Trump’s first administration, criticized Kennedy’s move to cancel $500 million for mRNA projects. Adams said in a post on social media platform X ...
HIV vaccine efforts have been slowed by the difficulty of getting neutralizing antibodies to target the correct locations of ...